Edition:
United Kingdom

Diplomat Pharmacy Inc (DPLO.N)

DPLO.N on New York Stock Exchange

4.51USD
6:09pm BST
Change (% chg)

$0.20 (+4.64%)
Prev Close
$4.31
Open
$4.31
Day's High
$4.55
Day's Low
$4.25
Volume
51,410
Avg. Vol
252,496
52-wk High
$28.74
52-wk Low
$4.17

About

Diplomat Pharmacy, Inc. (Diplomat) operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The Company operates through specialty pharmacy services segment. The Company's primary focus is on medication management programs... (more)

Overall

Beta: 0.77
Market Cap(Mil.): $322.02
Shares Outstanding(Mil.): 74.71
Dividend: --
Yield (%): --

Financials

  DPLO.N Industry Sector
P/E (TTM): -- 23.09 37.45
EPS (TTM): -4.26 -- --
ROI: -29.56 8.96 12.16
ROE: -52.35 0.13 16.93

Diplomat Pharmacy pulls forecast, delays results; shares hit record low

Diplomat Pharmacy Inc said on Friday it would withdraw its 2019 forecasts and delay its fourth-quarter and annual results as lower-than-expected performance in its pharmacy benefits management (PBM) business could result in a charge.

22 Feb 2019

UPDATE 2-Diplomat Pharmacy pulls forecast, delays results; shares hit record low

Feb 22 Diplomat Pharmacy Inc said on Friday it would withdraw its 2019 forecasts and delay its fourth-quarter and annual results as lower-than-expected performance in its pharmacy benefits management (PBM) business could result in a charge.

22 Feb 2019

Diplomat Pharmacy delays annual results after impairment charge

Feb 22 Diplomat Pharmacy Inc said on Friday it would delay its annual and fourth-quarter results after determining that the company will need to record a charge related to its pharmacy benefits management (PBM) business.

22 Feb 2019

Earnings vs. Estimates